Germany · Biotechnology
Pharmaceuticals
Biotechnology
Healthcare
BioNTech is committed to improving the health of people worldwide through fundamental research and development of immunotherapies and mRNA vaccines. The company combines scientific rigor, innovation, and passion to translate science into survival. BioNTech's therapeutic areas include oncology, infectious diseases, and other serious diseases. The company's approach involves leveraging the immune system's mechanisms to develop therapies and vaccines that improve standards of care or establish new ones.
2008
Founded
Biotechnology
Industry
Germany
Location
285,446,349
Ranking
5,000 employees
Size

Get full access to view complete information
